StreetInsider.com News Articles

Form 8-K SELLAS Life Sciences For: Jul 24

Mon, 27 Jul 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260727/26820178.html

Form 8-K SELLAS Life Sciences For: Jul 24

Mon, 27 Jul 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260727/26820178.html

SELLAS Life Sciences (SLS) call put ratio 6.5 calls to 1 put with a focus on a spreader of September 15 calls, September 15 calls, January 15 calls and January 30 calls

Mon, 13 Jul 2026 14:08:45 -0400

SELLAS Life Sciences (NASDAQ: SLS) 30-day option implied volatility is at 232; compared to its 52-week range of 81 to 236. Call put ratio 6.5 calls to 1 put with a focus on a spreader of September 15 calls, September 15 calls, January 15 calls and January 30 calls.

Form 8-K SELLAS Life Sciences For: Jun 24

Thu, 25 Jun 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260625/26688801.html

Form 8-K SELLAS Life Sciences For: Jun 24

Thu, 25 Jun 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260625/26688801.html

Form 4 SELLAS Life Sciences For: Jun 16 Filed by: Stergiou Angelos M.

Thu, 18 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26666579.html

Form 4 SELLAS Life Sciences For: Jun 16 Filed by: Stergiou Angelos M.

Thu, 18 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26666579.html

Form 8-K SELLAS Life Sciences For: Jun 16

Thu, 18 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26666598.html

Form 8-K SELLAS Life Sciences For: Jun 16

Thu, 18 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26666598.html

Form S-8 SELLAS Life Sciences

Tue, 16 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260616/26654562.html

Form S-8 SELLAS Life Sciences

Tue, 16 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260616/26654562.html

Form 8-K SELLAS Life Sciences For: Jun 02

Tue, 02 Jun 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260602/26588147.html

Form 8-K SELLAS Life Sciences For: Jun 02

Tue, 02 Jun 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260602/26588147.html

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare

SELLAS Life Sciences to Participate in Upcoming Investor Conferences

Thu, 14 May 2026 08:00:00 -0400

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will participate in the following upcoming investor conferences:

2026 Stifel Virtual Targeted Oncology Forum
Format: Corporate Presentation and Fireside Chat
Date and Time: Tuesday, May 19, 2026, at 2:00 PM ET
Location: New York, NY
Webcast Link: Click here

A.G.P.'s Annual Virtual Healthcare